![](/-/media/Images/News/2022/September-2022/0906RRCoronavirusMyocarditisBooster_SC.jpg?h=600&w=800&sc_lang=es&hash=A599248B7C280746B3A919B8667FAA7E)
Myocarditis from COVID-19 booster rare, but risk highest among teen boys, young men
Sep 6, 2022
Cases of myocarditis – an inflammation of the heart muscle – following a third dose of the Pfizer vaccine are rare and typically mild, research from Israel shows.